Just going by memory here but Don mentioned at the AGM that research was going on at Dalhousie U and McGill U wrt apabetalone being used to treat a couple of conditions RVX is interested in pursuing. He made the comment that it is nice to see this research being done where RVX doesn't have to pay for it. I can't remember if he said this when the slide was up showing future areas of interest or in the Q&A, but he definitely said it.